<DOC>
	<DOCNO>NCT01568749</DOCNO>
	<brief_summary>A study investigate pharmacokinetic profile four extend release paracetamol formulation</brief_summary>
	<brief_title>A Study Investigating Pharmacokinetic Profiles Four Extended Release Paracetamol Formulations</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Consent : Demonstrates understand study willingness participate evidence voluntary write informed consent receive sign date copy inform consent form . Age : Aged 18 50 year inclusive . Body Mass Index ( BMI ) : Body Mass Index must range 19 28 kg/m2 . Compliance : Understands willing , able likely comply study procedure restriction . General Health : Good general health ( opinion investigator ) clinically significant relevant abnormality medical history physical examination . Contraception : Females childbearing potential , opinion investigator , practice reliable method contraception . Pregnancy : Women pregnant positive serum pregnancy test . Breastfeeding : Women breastfeed . Allergy/Intolerance : Known suspected intolerance hypersensitivity study material ( closely relate compound ) state ingredient . Clinical Study/Experimental Medication : ) Participation another clinical study receipt investigational drug within 30 day screen visit . b ) Previous participation study . Substance abuse : Recent history ( within last 5 year ) alcohol substance abuse . Personnel : An employee sponsor study site member immediate family . Disease : ) Current recurrent disease could affect action , absorption disposition study medication clinical laboratory assessment ( e.g . hepatic disorder , renal insufficiency , congestive heart failure ) . b ) Current relevant previous history serious , severe unstable physical psychiatric illness , medical disorder may require treatment make subject unlikely fully complete study , condition present undue risk study medication procedure . Vegetarians : Subjects vegetarian . Hepatitis HIV Screening : Positive screening Serum Hepatitis B Surface Antigen , Hepatitis C Human Immunodeficiency Virus ( HIV ) . Medications : Current ( within 14 day screen ) regular use prescription , OTC , herbal medicine drug know induce inhibit hepatic drug metabolism 30 day prior dose , ( e.g . barbiturate , theophylline , cimetidine , erythromycin ) . Smoking : Nonsmokers le 3 month current use nicotinecontaining product . Blood : Subject donate experienced significant blood loss within 56 day Visit 2 , donate plasma within 7 day Visit 2 , hemoglobin value = 12.0 g/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>otc</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Paracetamol</keyword>
</DOC>